Levothyroxine Dosing Instructions
Administer levothyroxine as a single daily dose on an empty stomach, one-half to one hour before breakfast with a full glass of water, and separate it by at least 4 hours from medications that interfere with absorption. 1
Administration Timing and Method
- Take levothyroxine 30-60 minutes before breakfast on an empty stomach with a full glass of water to optimize absorption and prevent choking 1
- Separate levothyroxine by at least 4 hours from iron supplements, calcium supplements, and antacids that decrease absorption 1
- Evaluate need for dose adjustments when regularly administering within one hour of certain foods that may affect absorption 1
- For pediatric patients unable to swallow tablets, crush the tablet and suspend in 5-10 mL of water, administering immediately by spoon or dropper—do not store the suspension 1
- Do not administer in soybean-based infant formula, which decreases absorption 1
Initial Dosing Strategy
For Adults with Primary Hypothyroidism
The starting dose depends critically on age and cardiac status:
- Younger patients without cardiac disease: Start with near-full replacement dose of 1.6-1.8 mcg/kg of actual body weight 1, 2
- Elderly patients or those with cardiac disease: Start with a lower dose (typically 25-50 mcg daily) and titrate slowly to avoid cardiac complications 1, 3
- Patients at risk for atrial fibrillation: Use lower starting doses and slower titration 1
A prospective randomized trial demonstrated that full-dose initiation (1.6 mcg/kg) in cardiac asymptomatic patients is safe and achieves euthyroidism faster than low-dose regimens (25 mcg with gradual increases), with no cardiac events documented 2. However, this aggressive approach should be reserved for younger patients without cardiac risk factors.
Special Dosing Considerations by Etiology
Levothyroxine requirements vary significantly by the cause of hypothyroidism:
- Post-radioiodine therapy: Requires higher doses (approximately 1.92 mcg/kg) 4
- Post-thyroidectomy: Requires 1.5 mcg/kg for total thyroidectomy and 1.3 mcg/kg for lobectomy 4, 5
- Hashimoto's thyroiditis: Requires lower doses (approximately 1.25 mcg/kg) 4
- Atrophic thyroiditis: Requires the lowest doses (approximately 1.08 mcg/kg) 4
Obesity Adjustment
For obese patients, calculate dosing based on lean body mass rather than actual body weight:
- Use approximately 2.3 mcg/kg of lean body mass (calculated by Hume formula) for all BMI ranges 6
- Dosing by actual body weight in obese patients leads to overtreatment 6
- Underweight patients (body weight <50 kg) require particular attention due to increased susceptibility to hypothyroidism complications 7
Monitoring and Titration
Primary Hypothyroidism
Target serum TSH to the normal reference range (0.4-4.2 mIU/L):
- Monitor TSH and adjust dose until patient is clinically euthyroid with normalized TSH 1
- Peak therapeutic effect takes 4-6 weeks, so avoid dose adjustments more frequently 1
- For symptomatic patients with TSH in the upper half of normal range, consider increasing dose to bring TSH to lower portion of reference range 8
- Minimal TSH elevations may not require adjustment in patients who feel well, particularly those with arrhythmias or cardiac disorders 8
Secondary or Tertiary Hypothyroidism
Do not use TSH for monitoring—use serum free-T4 instead:
- Titrate levothyroxine until patient is clinically euthyroid and serum free-T4 is restored to the upper half of the normal range 1
- TSH is not a reliable measure of dosage adequacy in central hypothyroidism 1
Pregnancy-Specific Monitoring
Levothyroxine requirements frequently increase during pregnancy:
- Monitor serum TSH every 6-8 weeks during pregnancy and modify dose as needed 8
- Treat pregnant women or women planning pregnancy with elevated TSH to restore TSH to reference range, given associations with fetal wastage and neuropsychological complications 8
- The risks of appropriately managed levothyroxine therapy in pregnancy are minimal 8
Common Pitfalls and Caveats
Avoid over-replacement, which carries significant risks:
- Even minor over-replacement during initial titration should be avoided due to risk of cardiac events 3
- Chronic over-replacement may induce osteoporosis, particularly in postmenopausal women 3
- Subclinical hyperthyroidism from over-treatment increases risk of atrial fibrillation, cardiac dysfunction, and reduced bone mineral density 8
Recognize that achieving euthyroidism at first follow-up is challenging:
- Only approximately 33.9% of patients achieve euthyroidism at first follow-up after thyroidectomy, regardless of dosing strategy used 9
- This suggests need for close monitoring and expectation of dose adjustments 9
Never use levothyroxine for weight loss:
- Levothyroxine should not be used for obesity treatment or weight control in euthyroid patients 1
- Larger doses may produce serious or life-threatening toxicity, particularly with sympathomimetic amines 1
Consider formulation factors: